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Abstract
Dendritic cells express lectins receptors, like DC-SIGN, which allow these cells to sense glycans that are present on various
bacterial and viral pathogens. Interaction of DC-SIGN with carbohydrate moieties induces maturation of dendritic cells and
promotes endocytosis of pathogens which is an important property of these professional antigen presenting cells. Uptake
of pathogens by dendritic cells may lead to cross-presentation of antigens or infection of these cells, which ultimately
results in activation of virus-specific T cells in draining lymph nodes. Little is known about the interaction of DC-SIGN with
influenza A viruses. Here we show that a virus with a non-functional receptor binding site in its hemagglutinin, can replicate
in cells expressing DC-SIGN. Also in the absence of sialic acids, which is the receptor for influenza A viruses, these viruses
replicate in DC-SIGN expressing cells including human dendritic cells. Furthermore, the efficiency of DC-SIGN mediated
infection is dependent on the extent of glycosylation of the viral hemagglutinin.
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Introduction
DC-SIGN (dendritic cell-specific intercellular adhesion mole-
cule-3-grabbing nonintegrin) is a C-type lectin mainly present at
the surface of dendritic cells (DC). DC are antigen presenting cells
that play a key role in the induction of the adaptive immune
responses. They are able to present antigens to T cells and induce
their maturation. DC-SIGN signalling modulates the status of DC,
triggers their maturation and promotes the adaptive immune
response [1]. DC-SIGN belongs to the collectin family, and
recognizes glycans of pathogens. For example ligands of DC-SIGN
include bacteria and several viruses such as cytomegalovirus,
Dengue virus, Ebola virus, hepatitis C virus, human immunode-
ficiency virus 1, SARS-coronavirus and West Nile virus
[2,3,4,5,6,7,8,9,10]. Little is known about the interaction of DC-
SIGN with influenza A viruses.
Influenza A viruses belong to the family of the Orthomyxovir-
idae. Their genome consists of eight negative stranded RNA
segments which encode for eleven proteins. Two of these proteins,
hemagglutinin (HA) and neuraminidase (NA), protrude from the
viral envelope. They both recognize sialic acids on carbohydrate
side chains of cellular glycoproteins and glycolipids. HA binds to
sialic acids via its receptor binding site (RBS), which forms a
pocket of highly conserved amino acids [11,12,13]. After binding
to its receptor the virus is internalized via endocytosis. The low pH
of the endosome causes HA to undergo conformational changes
that lead to exposure of a fusion peptide and to fusion of the viral
and endosomal membranes. The RNA segments of the virus are
then delivered to the cytoplasm and transported to the nucleus,
where replication is initiated. The new virions are assembled at the
cell membrane and NA cleaves sialic acid at the cell membrane to
allow the newly synthesized virions to detach from the cell.
Sialic acids are a critical factor for the tropism of the virus,
because their type of linkage to a galactose residue determines
whether they are recognized by specific viruses [14,15]. Widely
present in the avian gastrointestinal tract, a(2,3) linked sialic acids
are preferably recognized by avian influenza A viruses [16,17]. On
the other hand, a(2,6) linked sialic acids are abundant in the
human upper respiratory tract and preferably recognized by
human influenza A viruses [18,19,20].
However, the binding of influenza A viruses to cells may not be
restricted to recognition of sialic acids by the RBS of HA. It was
found that lectin receptors can bind to influenza A viruses,
suggesting that other means of virus attachment and subsequent
entry could be involved [21,22,23,24]. Cellular lectin receptors
may recognize the glycans on HA, allow binding of the virus to the
cells and its internalization. Thus, the extent of glycosylation of
HA is likely to be important for the recognition of the virus by
cellular lectins. Glycosylation is achieved by post translational
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modification of Asparagine residues of the NXS/T motif (X can
be any amino acid except Proline). Numbers, types, and the
positions of glycans vary for each virus, which might affect
recognition of influenza viruses by lectin receptors such as DC-
SIGN. However, the role of DC-SIGN in binding and entry of
influenza viruses has been studied to a limited extent only
[23,25,26]. Only a limited number of viruses has been investigat-
ed. Furthermore, although a correlation between the extent of
glycosylation of viral envelope proteins and binding to DC-SIGN
has been suggested, solid evidence for this is largely lacking. In
addition, it is unclear if DC-SIGN mediated entry could support
productive infection.
By introducing two mutations, L194AY195F, in the RBS of HA
we created a mutant virus that was not able to bind to sialic acids.
This mutant served to prove that DC-SIGN could recognize HA
way and support virus replication. Then we selected nine H1N1
and H3N2 viruses to investigate whether the expression of DC-
SIGN in cell lines and DC could support replication of these
viruses in the absence of sialic acids. Furthermore, we genetically
modified two viruses, A/Netherlands/602/09 (H1N1pdm09) and
A/Netherlands/26/07 (H1N1), and inserted or deleted glycosyl-
ation sites on the head of HA and showed that binding efficiency
of DC-SIGN to HA and subsequent infection rates are determined
by the extent of glycosylation on the head of HA.
Finally we demonstrated that human DC can capture influenza
A virus through interaction with DC-SIGN which leads to
infection of these cells.
Materials and Methods
Cell lines
Madin-Darby Canine Kidney (MDCK) cells were cultured in
Eagle’s Minimum Essential medium; Vero cells in Dulbecco’s
Modified Eagle Medium. MDCK and Vero cells were stably
transfected with a plasmid expressing human DC-SIGN
(pcDNA3-DC-SIGN) that was kindly provided by Dr. V. Kewal
Ramani. 4 mg of the plasmid was nucleofected into MDCK and
Vero cells using the AmaxaH system (Lonza, Cologne, Germany).
The next day the cells were washed and cultured in the presence of
0.25 mg/ml of G148. MDCK and Vero cells expressing DC-
SIGN cells were isolated using CD209 MicroBeads (Miltneyi
Biotec, Germany) following the manufacturer’s instructions. DC-
SIGN expression was monitored by flow-cytometry after incuba-
tion with anti CD209 antibody labeled with phycoerythrin (PE).
After two passages MDCK DC-SIGN and Vero DC-SIGN cells
were cultured in the presence of 0.25 mg/ml of G148. DC-SIGN
expression was checked at each passage by flow cytometry.
DC-SIGN transgenic MDCK and Vero cells were generated
after permission of the ‘‘Committee Genetic Modification’’
(COGEM), permit number 99-090.
Viruses
An influenza virus with a deficient RBS was generated using
reverse genetics. The amino acids at the positions 194 and 195
were targeted since they are crucial for receptor binding
[11,12,27,28].
To this end, the HA gene segment of influenza virus A/Puerto
Rico/8/34 (A/PR/8/34) was modified by site directed mutagen-
esis (QuikChange multi site-directed mutagenesis kit, Stratagene,
Leusden, Netherlands) to yield HA with L194A and Y195F amino
acid substitutions [11,12,27,28].
Bidirectional reverse genetics plasmids [29,30] containing
wildtype (WT) or mutant HA were co-transfected into 293T cells
with a plasmid encoding the NA gene segment of which the
majority was replaced by the gene encoding Green fluorescent
protein (GFP) [30] and plasmids encoding the remaining six gene
segments of influenza virus A/PR/8/34. The supernatants were
used to subsequently inoculate MDCK or MDCK-DC SIGN cells
in the presence of neuraminidase from Vibrio cholerae (Sigma-
Aldrich, Saint Louis, MO) (3.4 U/ml). The viruses, designated
GFP-H1 and L194AY195F-GFP-H1 respectively, were used to
subsequently inoculate MDCK or MDCK DC-SIGN cells
(passage 2 and 3) (Figure 1).
Five H1N1 viruses (A/swine/Iowa/15/30, A/mallard/Nether-
lands/15/05, A/PR/8/34, A/USSR/90/77 and A/Netherlands/
364/06) and four H3N2 viruses (A/swine/oedenrode/7C/96, A/
Netherlands/35/93, A/Netherlands/312/03 and A/Nether-
lands/348/07) were selected and propagated in MDCK cells as
described previously [31]. The culture supernatants of infected
MDCK cells were clarified by low speed centrifugation, aliquoted
and stored at 280uC until use. Infectious virus titers were
determined as described previously [31].
A/Netherlands/602/09 and A/Netherlands/26/07 mutant
viruses were made as previously described [32]. The HA gene
segments of the two viruses were cloned into bidirectional reverse
genetics plasmids, [29,33]. By site-directed mutagenesis (Quik-
Change multi site-directed mutagenesis kit, Stratagene, Leusden,
Netherlands), the N-linked glycosylation sites were reciprocally
exchanged to produce viruses that gained or lost one or more
putative N-linked glycosylation sites. The plasmids encoding wild-
type or mutant HA genes were co-transfected into 293T cells with
plasmids encoding the remaining gene segments of back-bone
strain A/PR/8/34 (H1N1) as described previously. Here we used
A/Netherlands/26/07 and a mutant lacking one glycosylation site
A/Netherlands/26/07-D125. We also used A/Netherlands/602/
09, a mutant lacking one glycosylation site A/Netherlands/602/
09-D276 and a mutant that contains three additional glycosylation
sites that are present in A/Netherlands/26/07 (A/Netherlands/
602/09-VN54 N125 N160).
Replication curves and titration
Viruses L194AY195F-GFP-H1 and GFP-H1 passaged 2 or 3
times were used to inoculate MDCK or MDCK DC-SIGN cells at
a MOI of 0.01. As the titer of passage 1 was too low for virus
L194AY195F-GFP-H1, this passage was not used to determine
multi-step replication kinetics. Culture supernatants were collected
at 0, 6, 12, 24, 48 and 72 hours after inoculation and infectious
virus titers were determined in MDCK or MDCK DC-SIGN cells
as previously described [31].
Flow cytometry
Viruses L194AY195F-GFP-H1 and GFP-H1 that were pas-
saged 2 or 3 times were used to inoculate MDCK or MDCK DC-
SIGN cells at a MOI of 0.01. GFP expression in infected cells was
analyzed by flow cytometry at 24 and 48 hours post inoculation
using a FACS calibur and Cell Quest Pro software (Becton and
Dickinson).
Infection assay
MDCK and Vero cells were treated with 3.4 U/ml neuramin-
idase from Vibrio cholerae (Sigma Aldrich, Zwijndrecht, The
Netherlands) and GolgiStop (BD Biosciences, San Diego, CA) for
30 minutes to remove sialic acids from the cell surface. GolgiStop
is a protein transport inhibitor and its use results in the
accumulation of proteins in the Golgi complex.
Removal of sialic acids was confirmed by flow cytometry after
staining with biotin-labeled Sambucus nigra (SNA) lectin (1/50
dilution) that binds to a(2,6) linked sialic acids and Maackia
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amurensis (MAA) lectin that binds to a(2,3) linked sialic acids for
30 minutes and subsequent staining with streptavidine labeled
with fluorescein isothiocyanate (FITC) (Zebra Biosciences) follow-
ing the manufacturer’s instructions. We used a mixture of lectins
SNA and MAA (both Sanbio BV, Uden, The Netherlands) to
detect all sialic acid present on MDCK and Vero cells. This assay
was performed to confirm that NA treatment was effective and to
confirm the absence of both a2,3 and a2,6 sialosaccharides, which
are both present on MDCK cells [30]
Untreated cells were used as positive controls. After inoculation
with various viruses at a multiplicity of infection of 2 TCID50 per
cell for one hour in the presence of 3.4 u/ml neuraminidase from
vibrio cholerae and GolgiStop (BD Biosciences, San Diego, CA)
the inoculum was aspirated and the cells were washed and
incubated in culture medium for 16 hours. The cells were
transferred to a 96-wells V-bottom plate and washed twice with
PBS containing 2% Fetal Bovine Serum (P2F). They were stained
for viability using AmCyan-labeled Live/dead staining (Invitro-
gen, Oregon, USA). After washing with P2F, the cells were fixed
with 100 ml of cytofix (BD Biosciences, San Diego, CA) according
to the manufacturer’s recommendations. Subsequently, the cells
were washed twice with cytoperm (BD Biosciences, San Diego,
CA) and incubated with a monoclonal antibody specific for the
viral nucleoprotein, labeled with FITC (DAKOCytomation,
Glostrup, Denmark). After washing twice with P2F, the cells were
analyzed by flow cytometry using the DIVA H software. Each of
the assays described above, was optimized and validated carefully
using two different viruses A/Netherlands/364/06 and A/Nether-
lands/348/07. The reproducibility of the assays was confirmed by
performing the assays at least three times. The final experiment
with a large panel of viruses was performed in duplicate.
To confirm that entry was mediated by DC-SIGN, Vero and
Vero DC-SIGN were treated with neuraminidase from vibrio
cholerae for 30 minutes to remove sialic acids from the cell surface
and incubated with or without 5 mg of antibodies to DC-SIGN
(Abcam, Cambridge, UK) or an IgG2b isotype control (R&D
systems, Minneapolis) or 40 mg/ml of mannose. These cells were
subsequently inoculated with influenza virus (A/NL/312/03 or
A/USSR/90/77). The percentage of infected cells compared to
the positive control (untreated cells, still possessing of sialic acid)
was assessed as described above. The infection assay experiments
were performed in duplicate
Dendritic cells
Peripheral blood mononuclear cells (PBMC) obtained from 3
healthy blood donors were isolated using Lymphoprep (Nycomed,
Oslo, Norway) gradient centrifugation and cryopreserved at
2135uC. Blood was obtained from Bloodbank Sanquin, region
South West Netherlands, Rotterdam (Research permission num-
ber 10.084). Permission to use the PBMC for scientific research
was obtained by informed consent. Dendritic cells were purified by
MACS H CD14 beads sorting (Miltenyi Biotec, Bergish Gladbach,
Germany) and cultured for 7 days in the presence of 1000 u/mL
GM-CSF and 200 u/mL IL-4. Then, DC were treated with
3.4 u/ml neuraminidase from vibrio cholerae (Sigma Aldrich,
Zwijndrecht, The Netherlands) for 30 minutes to remove sialic
acids present at the cell surface and incubated with 5 mg of
monoclonal antibody to DC-SIGN (Abcam, Cambridge, UK) or
an IgG2b isotype control (R&D systems, Minneapolis) to test if
blocking DC-SIGN could inhibit infection of DC. They were
subsequently inoculated overnight at a MOI of 3 with influenza
viruses A/Netherlands/348/07 and A/Netherlands/312/03 in
the presence of 3.4 u/ml neuraminidase from Vibrio cholerae
(Sigma Aldrich, Zwijndrecht, The Netherlands). Subsequently the
percentage of infected DC was assessed as described above. After
optimization and validation, the final experiment was performed
in triplicate.
Figure 1. Schematic representation of the passage history and infection experiments with influenza viruses GFP-H1 and
L194AY195F-GFP-H1.
doi:10.1371/journal.pone.0056164.g001
Figure 2. DC-SIGN expression in stably transfected MDCK DC-
SIGN and Vero DC-SIGN cells. MDCK cells (A) and Vero cells (B)
without (dotted line) and transfected with the gene encoding DC-SIGN
(solid line) were analyzed for DC-SIGN expression after staining with a
PE-labeled antibody to DC-SIGN and flow cytometry.
doi:10.1371/journal.pone.0056164.g002
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Results
DC-SIGN expressing cell lines
MDCK and Vero cells were stably transfected to express
human DC-SIGN. The expression of DC-SIGN was assessed by
flow-cytometry (figure 2). Typically .95% of cells expressed DC-
SIGN.
Replication kinetics
Viruses L194AY195F-GFP-H1 and GFP-H1 (passages 2 and 3)
were used to inoculate MDCK or MDCK DC-SIGN cells at a
MOI of 0.01 and culture supernatants were collected at various
time points post inoculation (figure 1). The infectious virus titers
were then determined in MDCK and MDCK DC-SIGN cells.
Figure 3. Replication kinetics of viruses GFP-H1 and L194AY195F-GFP-H1 in MDCK and DC-SIGN-expressing MDCK cells. After
transfection of 293T cells with reverse genetics plasmids, culture supernatants of influenza viruses GFP-H1 (A, C, E, G) and L194AY195F-GFP-H1 (B, D,
F, H) virus passaged in MDCK (A–D) and MDCK-DC-SIGN (E–H) cells were obtained and used to inoculate MDCK (solid symbols) or MDCK DC-SIGN cells
(open symbols) at a moi of 0.01. At the indicated time points post inoculation culture supernatant were tested for the infectious virus titers to
determine the replication kinetics. Virus L194AY195F-GFP-H1 could not be rescued in MDCK cells.
doi:10.1371/journal.pone.0056164.g003
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The results are shown in figure 3. GFP-H1 virus replicated both in
MDCK and MDCK DC-SIGN cells and after 24 hours the virus
titers reached between 106.5 and 108.25 TCID50/ml after
inoculation of MDCK or MDCK DC-SIGN cells for passage 2
and 3, respectively.
In contrast to virus GFP-H1, virus L194AY195F-GFP-H1 could
not be rescued in MDCK cells (after five independent attempts)
and no infectious virus was detectable after two subsequent
passages in these cells (figure 3). However, upon passage in
MDCK DC-SIGN cells, virus L194AY195F-GFP-H1 could
readily be propagated although the titers that were reached were
lower than for virus GFP-H1 (103.5 and 105.25 TCID50/ml
48 hours after inoculation of MDCK DC-SIGN cells for passage 2
and 3, respectively). After two passages in MDCK DC-SIGN cells,
replication of virus L194AY195F-GFP-H1 in MDCK cells was
undetectable, whereas after three passages a virus titer of 103.5
TCID50/ml was reached in MDCK cells 72 hours post inocula-
tion, which was almost 100-fold lower than the titer reached in
MDCK DC-SIGN cells 48 hours post inoculation.
Infection monitored by GFP expression
Viruses L194AY195F-GFP-H1 and GFP-H1 (passages 2 and 3)
were used to inoculate MDCK or MDCK DC-SIGN cells at a
MOI of 0.01 and the expression of GFP was assessed by flow
cytometry at 24 (figure 4) and 48 hours (data not shown) post
inoculation.
The results confirmed that virus GFP-H1 with a functional HA
molecule was able to infect MDCK and MDCK DC-SIGN cells
regardless of the cell line that was used to produce this virus
(figures 4A).
As shown in figure 4B, influenza A virus L194AY195F-GFP-H1
obtained after two or three passages in MDCK DC-SIGN cells
infected a larger proportion of MDCK DC-SIGN cells than
MDCK cells (arrows), which is in accordance with the differences
in replication kinetics observed between the two cell lines.
Influenza A viruses can infect cells via DC-SIGN in the
absence of sialic acid
In order to remove sialic acids, the normal receptor for
influenza A viruses, MDCK and Vero cells were treated with
neuraminidase from Vibrio cholera. The success of this treatment
was confirmed by flow cytometry using biotin-labeled lectins MAA
and SNA (Figure S1). Untreated cells were used as positive
controls for inoculation and the infection percentage of these cells
were assessed. First we compared infection rates of untreated
MDCK with MDCK DC-SIGN cells and Vero and Vero DC-
SIGN cells. As expected the infection percentages did not differ
significantly between cells that expressed DC-SIGN and those that
did not. (Figure S2) (R2 values were of 0.7795 and 0.6416 for Vero
and MDCK cells respectively). Since viruses displayed different
infection rates, the infection rates were expressed relative to the
positive control with sialic acids.
All nine viruses that were tested were able to infect MDCK,
MDCK DC-SIGN, Vero and Vero DC-SIGN cells in the
presence of sialic acids.
After removal of sialic acids from MDCK and Vero cells, the
infection percentages relative to the untreated positive controls
dropped considerably for most viruses. The mean relative number
of infected cells was 13.6 and 2.0% for Vero cells and MDCK cells
respectively (Figure 5). However, in the absence of sialic acids the
expression of DC-SIGN supported the infection of MDCK cells
and Vero cells by a number of influenza A viruses including two
H1N1 viruses, A/USSR/90/77 and A/Netherlands/364/06, and
four H3N2 viruses, A/swine/Oedenrode/7C/96, A/Nether-
lands/35/93, A/Netherlands/312/03 and A/Netherlands/348/
07. Especially influenza A/H3N2 viruses A/Netherlands/312/03
and A/Netherlands/348/07 displayed high infection percentages,
comparable to those of untreated control cells. A/H1N1 viruses
A/swine/Iowa/15/30, A/mallard/Netherlands/15/05 and A/
PuertoRico/8/34 displayed low infection percentages in MDCK-
DC-SIGN cells devoid of sialic acids (0%, 1.9% and 2.6%
respectively) and in Vero DC-SIGN cells (3.6%, 10.9% and 3.1%
respectively) (figure 5 A and B). The differences observed between
viruses may be explained by differences in the number of N-linked
glycosylation sites present on HA (table 1). The number of putative
N-linked glycosylation sites predicted with the online software
NGlycNet correlated with DC-SIGN mediated infection of the
cells. However, it remains unclear to which extent these
glycosylation sites are in fact utilized.
To confirm that entry of these viruses was mediated via DC-
SIGN, Vero and Vero DC-SIGN cells were incubated with DC-
Figure 4. GFP expression after infection with L194AY195F-GFP
and GFP-H1 in MDCK and DC-SIGN-expressing MDCK cells.
MDCK and MDCK DC-SIGN cells were inoculated with influenza viruses
GFP-H1 (A) and L194AY195F-GFP-H1 (B) at a MOI of 0.01 (solid lines).
Both viruses were passaged in MDCK-DC-SIGN cells two or three times
as indicated. Twenty-four hours post inoculation the cells were tested
for GFP expression by flow cytometry. Uninfected cells were included as
negative controls (dotted lines). Infection experiments with GFP-H1
virus passaged in MDCK cells essentially gave the same results as the
virus passaged in MDCK DC-SIGN cells (data not shown).
doi:10.1371/journal.pone.0056164.g004
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SIGN blocking antibodies and subsequently infected with influ-
enza viruses A/NL/312/03 and A/USSR/90/77. As shown in
figure 5 E and F, the infection rates were reduced in the presence
of these antibodies but not in the presence of control antibodies of
the same isotype. Furthermore, also in presence of mannose, the
entry was blocked, indicating that DC-SIGN was functional and
able to bind to mannan.
Influenza A viruses can infect DC via DC-SIGN
DC from three different healthy blood donors were isolated,
treated with neuraminidase from Vibrio cholerae or not and
subsequently inoculated with A/H3N2 viruses. Infection rates of
DC obtained from different donors varied. Donor 1 displayed
6.6% and 20.3% infected cells after infection with A/Nether-
lands/348/07 and A/Netherlands/312/03 respectively. Donor 2
showed 5% and 9.6% infected cells after infection with A/
Netherlands/348/07 and A/Netherlands/312/03 respectively
and donor 3 displayed infection rates of 37% and 65%
respectively. In the absence of sialic acids the infection percentages
were reduced and ranged between 6 and 23% of those of
untreated DC, depending on the virus and blood donor tested
(figure 6). However, in presence of blocking anti-DC-SIGN
antibodies this percentage further decreased significantly
(p,0.05, Mann-Whitney test) whereas addition of control
Figure 5. Expression of DC-SIGN supports replication of influenza A viruses in the absence of sialic acids. MDCK (A and C) and Vero
cells (B and D) transfected with the DC-SIGN gene (black bars) or not (white bars), were treated with neuraminidase from vibrio cholerae and
GolgiStop for 30 minutes to remove sialic acids from the cell surface. These cells were subsequently inoculated with five different A/H1N1 viruses (A
and B) and four A/H3N2 viruses (C and D). The percentage infected cells relative to the untreated control cells, still possessing sialic acid, was assessed
after detecting infected cells using a FITC-labelled antibody to the viral nucleoprotein and flow-cytometry. To confirm that the entry was mediated
via DC-SIGN, Vero and Vero DC-SIGN were treated with neuraminidase from vibrio cholerae for 30 minutes to remove sialic acids from the cell surface
and incubated with or without antibodies to DC-SIGN or an isotype control antibody as indicated (E and F). These cells were subsequently inoculated
with influenza viruses. NL/312/03 and USSR/90/77. The percentage of infected cells compared to the positive control (untreated cells, still possessing
sialic acid) was assessed as described above.
doi:10.1371/journal.pone.0056164.g005
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antibody did not have a significant effect on the infection
percentages.
Effect of glycosylation of HA on DC-SIGN mediated
infection
Since DC-SIGN interacts with glycans present on membrane
glycoproteins, we wished to investigate the effect of N-linked
glycosylation of HA on binding to, and infection of, DC-SIGN
expressing cells. To this end, we selected two viruses A/Nether-
lands/602/09 (H1N1pdm09) and A/Netherlands/26/07 (H1N1)
and of which modification glycosylation sites on the head of the
hemagglutinin were inserted or deleted. Influenza A virus A/
Netherlands/26/07 infected DC-SIGN expressing Vero and
MDCK cells, but hardly cells not expressing DC-SIGN
(Figure 7). However, deletion of the glycosylation site at position
125 of HA (A/Netherlands/26/07-D125) severely impaired the
capacity to infect cells in a DC-SIGN dependent fashion (figure 7).
Influenza A virus A/Netherlands/602/09 displayed a low
infection percentage in MDCK DC-SIGN (13.7%+/20.2%)
and Vero DC-SIGN cells (11.5%+/20.3%), which was compa-
rable to those of cells not expressing DC-SIGN. Influenza A virus
A/Netherlands/602/09 lacking the N-linked glycosylation sites at
position 276 (D276) infected cells, including DC-SIGN expressing
cells, inefficiently. In contrast, insertion of three glycosylation sites
in HA of A/Netherlands/602/09 (A/Netherlands/602/09-VN54
N125 N160), increased infection percentages of DC-SIGN
expressing cells considerably compared to wild type virus and this
virus infected DC-SIGN expressing cells almost as good as
untreated cells with sialic acids on their surface (96%+/21% and
70.6%+/23% for MDCK DC-SIGN and Vero DC-SIGN,
respectively).
Discussion
In the present study we show that expression of DC-SIGN
facilitates infection of cells by influenza A viruses independent of
sialic acids, the natural receptor for these viruses, expressed on the
target cell
First we generated a virus with mutations in its receptor binding
site. It proved impossible to rescue virus L194AY195F-GFP-H1 in
MDCK cells. However, using MDCK cells constitutively express-
ing DC-SIGN this virus was readily rescued. Furthermore, the
Table 1. Number of putative N linked glycosylation sites present in HA1 and in HA2 of the viruses used in this study.
Virus Number of putative glycosylation sites in Predicted number of glycosylation sites in
HA1 HA2 HA1 HA2
swine/Iowa/15/30 1 5 1 4
mallard/NL/15/05 ND ND ND ND
PuertoRico/8/34 1 6 4 5
USSR/90/77 4 6 3 5
NL/364/06 4 5 4 5
swine/oedenrode/7C/96 4 6 3 4
NL/35/93 2 5 1 4
NL/312/03 7 4 6 4
NL/348/07 7 4 5 3
The software NetNGlyc (http://www.cbs.dtu.dk/services/NetNGlyc/)was used to predict the number of glycosylation sites that will be utilized.
doi:10.1371/journal.pone.0056164.t001
Figure 6. DC-SIGN expression on DC supports replication of influenza virus in absence of sialic acids. DC were treated with
neuraminidase from vibrio cholerae for 30 minutes to remove sialic acids from the cell surface and incubated with or without antibodies to DC-SIGN
or an isotype control antibody as indicated. These cells were subsequently inoculated with two A/H3N2 influenza viruses. The percentage of infected
cells compared to the positive control (untreated cells, still possessing of sialic acid) was assessed as described above.
doi:10.1371/journal.pone.0056164.g006
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mutant virus replicated better in DC-SIGN expressing cells than in
normal MDCK cells. However, after three passages in MDCK
DC-SIGN cells, virus L194AY195F-GFP-H1 displayed some
replication in MDCK cells 48 hours post inoculation, although
the kinetics of replication was delayed and the extent of replication
reduced compared to that in MDCK cells expressing DC-SIGN.
We determined the nucleotide sequence after each passage and
did not find any sign of reversion of the RBS to the wild type
sequence, although the emergence of minor variants that bind
sialic acid cannot be excluded. Of interest, it has been recently
demonstrated that influenza A viruses can enter CHO cells in a
sialic acid independent way, although the exact mechanism
remains elusive [34]. Alternatively, MDCK cells may support
replication of the mutant virus by another unknown, but
inefficient, way. Of note, we used A/PR/8/34 for generating a
RBS deficient virus. However, in the absence of sialic acids, this
virus replicated relatively poorly in DC-SIGN expressing MDCK
and Vero cells, which may be related to the relative low number of
N-Linked glycosylation sites in its HA and which may have
reduced the window of opportunity to measure differences in
infection rates in cells with and without DC-SIGN.
Next we explored an opposite approach, by removing the
natural receptor for influenza A viruses from MDCK and Vero
cells by treatment with neuraminidase and assessed the effect of
DC-SIGN expression on infection ratesof nine different influenza
A viruses of the H1N1 and H3N2 subtypes obtained from various
species. Indeed for most viruses tested, the presence of DC-SIGN
mediated virus entry and infection of the cells which can be
explained by binding of DC-SIGN to glycans on the HA of these
viruses, followed by endocytosis of the virus and fusion of the viral
envelope with the endosomal membrane, the initial steps in the
virus replication cycle. Of interest, the viruses that displayed
efficient DC-SIGN mediated infection in the absence of sialic
acids, had relatively large number of putative N-linked glycosyl-
ation sites on their HA
In order to confirm that indeed the interaction between DC-
SIGN and glycans on HA are at the basis of the observed
increased infection percentages in DC-SIGN expressing cells, we
used genetically modified influenza A/H1N1 viruses, A/Nether-
lands/26/07 and A/Netherlands/602/09 (H1N1pdm09), of
which N-linked glycosylation sites were reciprocally exchanged
to produce viruses that gained or lost one or more putative N-
linked glycosylation sites. In general, removal of N-linked
glycosylation sites, reduced DC-SIGN mediated infection of
MDCK and Vero cells, whereas addition of N-linked glycosylation
sites increased infection of these cells (figure 7). Thus, DC-SIGN
can act as an alternative receptor for influenza A viruses by
binding to glycans present on HA and can initiate the virus
replication cycle. Although, it has been suggested that the extent of
glycosylation of HA determine the efficiency of recognition by
DC-SIGN [25], we provide here for the first time solid evidence
that this indeed is the case using a large panel of viruses and
isogenic viruses with mutations in N-linked glycosylation sites only.
Of interest, it was also suggested that H5N1 viruses can bind to
DC-SIGN [23]. However, little infection of DC-SIGN expressing
cells was observed after sialidase treatment of the cells. This might
be explained by poor utilization of putative N-linked glycosylation
sites in HA of the virus used, preventing binding to DC-SIGN.
This was also observed after investigating the binding of H5N1
viruses to soluble C-type lectins such as porcine surfactant protein
D [35].
Finally, we tested if DC, the cells of interest expressing DC-
SIGN in vivo [36,37] in addition to human alveolar macrophages
[38], also can use this receptor for binding influenza A viruses. To
this end, sialic acids were removed and it was shown that the
infection of DC could be inhibited by a monoclonal antibody
specific for DC-SIGN. Thus, DC can become infected in the
absence of sialic acids after binding to glycans present on HA of
influenza A virus as suggested previously for an H5N1 virus and
DC cocultured with MDCK cells [23]. Most likely, the non-
specific binding of glycosylated pathogens is a universal property
of DC and may contribute to the induction of adaptive immune
responses to these pathogens. Our findings may implicate that
heavily glycosylated influenza A viruses more efficiently infect DC
Figure 7. The number of glycosylation sites present on HA determines the virus infection rates in DC-SIGN expressing cells. MDCK
(A) and Vero (B) cells, transfected with the DC-SIGN gene (black bars) or not (white bars) were treated with neuraminidase from vibrio cholerae and
GolgiStop for 30 minutes to remove sialic acids from the cell surface. These cells were subsequently inoculated with A/Netherlands/26/07, A/
Netherlands/26/07-D125, A/Netherlands/602/09, A/Netherlands/602/09-D276 or A/Netherlands/602/09-VN54 N125 N160. The percentage of infected
cells relative to the positive control (untreated cells still possessing sialic acid) was assessed after detecting infected cells using a FITC-labeled
antibody to the viral nucleoprotein and flow-cytometry.
doi:10.1371/journal.pone.0056164.g007
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and subsequently may induce stronger immune responses than
viruses that are less heavily glycosylated. Indeed the extent of
glycosylation was shown to be inversely correlated with the
virulence of influenza A viruses [39,40,41], which was attributed
to increased sensitivity to the action of collectins, defence
molecules of the innate immune system. Increased susceptibility
to infection of DC may further blunt infection by heavily
glycosylated influenza A viruses.
Collectively, we have shown that DC-SIGN can capture
influenza A viruses and support infection of cells that express
DC-SIGN. The efficiency of this process is dependent of the extent
of glycosylation of the viral HA. Further research is required to
relate the extent of DC-SIGN mediated infection of DC to the
magnitude of the immune response to infection, the virus specific
T cell response in particular.
Supporting Information
Figure S1 Removal of sialic acids from cells by treatment with
neuraminidase. Vero and MDCK cells were treated with
neuraminidase from vibrio cholerae and GolgiStop for 30 minutes
to remove sialic acids from the cell surface. After incubation with a
mixture of biotin-labelled lectins SNA and MAA and subsequently
with FITC-labelled streptavidin, the removal of sialic acids was
confirmed by flow cytometry (in grey). The dotted line represents
unstained cells and the black line cells represent the background
staining of cells that were incubated with FITC-labelled
streptavidin only.
(TIF)
Figure S2 Comparison of infection rates of MDCK and Vero
cells with those expressing DC-SIGN after inoculation with 13
different viruses used in the present study at a multiplicity of
infection of 2 TCID50 per cell. Each symbol represents an
individual virus. These infection rates were used to calculate the
‘‘percentage of infection compared to positive control’’ showed in
figure 5 and 6.
(TIF)
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